Loading data for DRTS — first visit, this takes a few seconds.
Alpha Tau Medical Ltd. (DRTS)
NasdaqCM: DRTS
· 即時價格 · USD
14.95
-0.08 (-0.53%)
收盤價： Sep 08, 2026, 4:47 PM
股價、關鍵數字和最新消息，都在這一頁。
Alpha Tau Medical Ltd.（DRTS）股價、分析與資料
無可用資料
| 買價 | 10.83 |
| 市值 | 1.38B |
| 營收 (ttm) | n/a |
| 淨利（ttm） | -92.6M |
| 1.21 | |
| -1.04 | |
| n/a | |
| -28.61 | |
| P/B (ttm) | 31.34 |
| P/S (ttm) | 0.00 |
| 財報日期 | Nov 19, 2026 |
| 賣價 | 18.77 |
| 成交量 | 355,704 |
| 20 日平均成交量 | 688,896 |
| 開盤價 | 15.03 |
| 前收盤價 | 15.03 |
| 當日區間 | 14.47 - 15.08 |
| 52 週範圍 | 3.43 - 15.17 |
| 分析師 | n/a |
| 目標價 | n/a |
| 股利 | n/a |
| 除息日 | n/a |
關於 DRTS
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors. The ...
完整的公司簡介財報驚奇
Alpha Tau Medical 已於 Aug 10, 2026 公布季度財報：
- 營收為 $0 低於預期 $0, 年增 NaN% 成長.
- 每股盈餘為 -0.5 低於預期 -0.36, 年增 -284.62% 下滑.
第 1 頁，共 2 頁